Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Recruiting · NCT06954597 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis | Skin and Connective Tissue Diseases, connective tissue disorder, digital ulcers, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2026-10-01 | NCT06954597 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bioskin GmbH | 2 |
| Topadur Pharma AG | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier Universitaire de Bordeaux, Service de Rhumatologie | Bordeaux | France | 1 |
| CHRU Lille, Hôpital Claude Huriez, Rue Michel Polonosvski | Lille | France | 1 |
| CHU Grenoble Alpes | La Tronche | France | 1 |
| Hôpital Cochin | Paris | France | 56 |
| Reha Rheinfelden, Salinenstrasse 98 | Rheinfelden | Switzerland | 1 |
| Universitätsspital Zürich, Klinik für Rheumatologie, Rämistrasse 100 | Zurich | Switzerland | 1 |